DK137990B - Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 1-arylpropyl-(2)-piperazinderivater eller syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 1-arylpropyl-(2)-piperazinderivater eller syreadditionssalte deraf

Info

Publication number
DK137990B
DK137990B DK373271AA DK373271A DK137990B DK 137990 B DK137990 B DK 137990B DK 373271A A DK373271A A DK 373271AA DK 373271 A DK373271 A DK 373271A DK 137990 B DK137990 B DK 137990B
Authority
DK
Denmark
Prior art keywords
arylpropyl
racemic
preparation
optically active
piperazine derivatives
Prior art date
Application number
DK373271AA
Other languages
English (en)
Other versions
DK137990C (da
Inventor
E O Renth
A Mentrup
K Schromm
R Gisemann
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Priority to DK510677A priority Critical patent/DK140666B/da
Publication of DK137990B publication Critical patent/DK137990B/da
Application granted granted Critical
Publication of DK137990C publication Critical patent/DK137990C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/56—Radicals substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK373271A 1970-07-30 1971-07-29 Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 1-arylpropyl-(2)-piperazinderivater eller syreadditionssalte deraf DK137990C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK510677A DK140666B (da) 1970-07-30 1977-11-17 Fremgangsmåde til fremstilling af N-(1-(3,4-methylendioxyphenyl)-propyl-(2))-N'-(alfa-naphthyl)-piperazin eller syreadditionssalte heraf.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2037852A DE2037852C3 (de) 1970-07-30 1970-07-30 Neue Piperazinderivate und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
DK137990B true DK137990B (da) 1978-06-19
DK137990C DK137990C (da) 1978-11-13

Family

ID=5778382

Family Applications (1)

Application Number Title Priority Date Filing Date
DK373271A DK137990C (da) 1970-07-30 1971-07-29 Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 1-arylpropyl-(2)-piperazinderivater eller syreadditionssalte deraf

Country Status (19)

Country Link
US (1) US3808212A (da)
JP (1) JPS5716989B1 (da)
AT (6) AT311976B (da)
AU (1) AU463957B2 (da)
BE (1) BE770800A (da)
BG (5) BG20370A3 (da)
CH (6) CH565781A5 (da)
CS (1) CS172929B2 (da)
DE (1) DE2037852C3 (da)
DK (1) DK137990C (da)
ES (6) ES393738A1 (da)
FR (1) FR2100972B1 (da)
GB (1) GB1344720A (da)
NL (1) NL173643C (da)
PL (6) PL84349B1 (da)
RO (6) RO59997A (da)
SE (2) SE375308B (da)
SU (4) SU437292A3 (da)
YU (7) YU34530B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940396A (en) * 1973-02-28 1976-02-24 Uniroyal Inc. 1,2,3,4,4A,5,7,7A-Octahydrothieno[3,4-b]pyrazines 6,6-dioxides
US3991036A (en) * 1973-02-28 1976-11-09 Uniroyal Inc. Preparation of polyurethane using 1,2,3,4,4a,5,7,7a-Octahydrothieno[3,4-b]py
GB1407552A (en) * 1973-04-02 1975-09-24 Science Union & Cie Disubstituted piperazines processes for their preparation and pharmaceutical compositions containing them
GB1432660A (en) * 1973-10-30 1976-04-22 Science Union & Cie Piperazine derivatives processes for their preparation and and pharamacueitcal compositions containing them
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
DE2604838A1 (de) * 1976-02-07 1977-08-11 Knoll Ag Alkylendioxypiperazinderivate
DE3476196D1 (en) * 1983-01-21 1989-02-23 Fisons Plc Aromatic amines
DE3571436D1 (en) * 1984-12-21 1989-08-17 Duphar Int Res New pharmaceutical compositions having anti-psychotic properties
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
US6002005A (en) * 1995-06-02 1999-12-14 Neurogen Corporation Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands
FR2737724B1 (fr) * 1995-08-09 1997-09-05 Synthelabo Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4- (naphtalen-1-yl) piperazine, leur preparation et leur application en therapeutique
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
US6040448A (en) * 1997-10-24 2000-03-21 Neurogen Corporation Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands
MA41169A (fr) * 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132357C (da) * 1966-09-03

Also Published As

Publication number Publication date
AU3177271A (en) 1973-02-01
BE770800A (fr) 1972-01-31
ES396215A1 (es) 1974-04-16
YU34888B (en) 1980-04-30
DE2037852B2 (de) 1979-10-11
CH575412A5 (da) 1976-05-14
AT311986B (de) 1973-12-10
ES396213A1 (es) 1974-04-16
SU437291A3 (ru) 1974-07-25
YU35248B (en) 1980-10-31
BG21029A3 (bg) 1976-01-20
FR2100972B1 (da) 1974-11-15
ES396212A1 (es) 1974-04-16
SU416945A3 (ru) 1974-02-25
BG19598A3 (da) 1975-06-25
SE7408533L (da) 1974-06-27
SU437289A3 (ru) 1974-07-25
BG20370A3 (bg) 1975-11-05
AT311988B (de) 1973-12-10
YU34890B (en) 1980-04-30
PL84348B1 (da) 1976-03-31
PL84664B1 (da) 1976-04-30
YU60078A (en) 1979-10-31
ES396216A1 (es) 1974-04-16
PL84349B1 (da) 1976-03-31
BG20594A3 (da) 1975-12-05
RO60596A (da) 1976-08-15
CH565781A5 (da) 1975-08-29
SU437293A3 (ru) 1974-07-25
YU138878A (en) 1982-10-31
DK137990C (da) 1978-11-13
DE2037852A1 (de) 1972-02-03
SU440840A3 (da) 1974-08-25
YU59778A (en) 1980-04-30
RO59997A (da) 1976-06-15
AU463957B2 (en) 1975-08-14
CH565165A5 (da) 1975-08-15
CS172929B2 (da) 1977-01-28
AT311984B (de) 1973-12-10
NL7110538A (da) 1972-02-01
YU59978A (en) 1979-10-31
SU437290A3 (ru) 1974-07-25
AT311985B (de) 1973-12-10
YU34889B (en) 1980-04-30
ES393738A1 (es) 1974-07-01
NL173643C (nl) 1984-02-16
RO60597A (da) 1976-08-15
SU437292A3 (ru) 1974-07-25
SE403288B (sv) 1978-08-07
GB1344720A (en) 1974-01-23
CH565166A5 (da) 1975-08-15
FR2100972A1 (da) 1972-03-24
YU59878A (en) 1979-10-31
YU59678A (en) 1979-10-31
PL84347B1 (da) 1976-03-31
DE2037852C3 (de) 1980-06-26
NL173643B (nl) 1983-09-16
AT311987B (de) 1973-12-10
SE375308B (da) 1975-04-14
US3808212A (en) 1974-04-30
YU34891B (en) 1980-04-30
RO61040A (da) 1976-08-15
CH565167A5 (da) 1975-08-15
PL84610B1 (da) 1976-04-30
RO60599A (da) 1976-08-15
CH565780A5 (da) 1975-08-29
PL91965B1 (da) 1977-03-31
ES396214A1 (es) 1974-04-16
JPS5716989B1 (da) 1982-04-08
YU34530B (en) 1979-09-10
RO60598A (da) 1976-07-15
AT311976B (de) 1973-12-10
BG20369A3 (bg) 1975-11-05
YU198671A (en) 1979-02-28

Similar Documents

Publication Publication Date Title
DK135585C (da) Analogifremgangsmade til fremstilling af cycloheptenderivatereller syreadditionssalte deraf
DK131858C (da) Analogifremgangsmade til fremstilling af 4-amino-6-arylpyrimidin-forbindelser eller syreadditionssalte deraf
DK139387C (da) Analogifremgangsmaade til fremstilling af apovincaminsyrederivater eller syreadditionssalte deraf
DK137990C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 1-arylpropyl-(2)-piperazinderivater eller syreadditionssalte deraf
DK124081B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive piperazinderivater eller syreadditionssalte deraf.
DK132944C (da) Analogifremgangsmade til fremstilling af 4-(4-biphenylyl)-4-oxo-smorsyrer eller estere eller salte heraf
DK131778C (da) Fremgangsmade til fremstilling af substituerede 3-hydroksymetylisokinolinderivater eller syreadditionssalte heraf
DK137677C (da) Analogifremgangsmaade til fremstilling af basisk substitueredexanthinderivater eller syreadditionssalte heraf
DK137606C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenylamino-imidazoliner-(2) eller syreadditionssalte deraf
DK139582B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK133980C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive diphenylalkyllactamimidderivater eller syreadditionssalte deraf
DK131857C (da) Analogifremgangsmade til fremstilling af 4-hydroxymethyl-1-phthalazonderivater eller syreadditionssalte deraf
DK142984C (da) Analogifremgangsmaade til fremstilling af benzobicycloalkanaminer eller farmaceutisk acceptable syreadditionssalte deraf
DK139517C (da) Analogifremgangsmaade til fremstilling af substituerede thiazol-2-carboxamider eller syreadditionssalte deraf
DK133555C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive n-thienylmethyl-heterocycliske forbindelser eller syreadditionssalte deraf
DK130958B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropaner eller fysiologisk tålelige syreadditionssalte heraf.
DK132627C (da) Analogifremgangsmade til fremstilling af kromanderivater eller syreadditionssalte deraf
DK133149B (da) Analogifremgangsmade til fremstilling af et guanidinphenylurinstofderivat eller syreadditionssalte deraf
DK132551C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive carbamoylalkoxyphenoxyisopropanolaminderivater eller syreadditionssalte deraf
DK135941C (da) Analogifremgangsmaade til fremstilling af 1-cyclopropyl-1-phenyl-3-amino-1-propanoler eller syreaddittionssalte deraf
DK133005C (da) Analogifremgangsmade til fremstilling af racemisk eller optisk aktiv 1-cyclohexenyl-glycinamidopenicillansyre eller -cephalosporansyrer eller salte deraf
DK135942C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive 1-(m-acyloxyphenyl)-1-hydroxy-2-n-alkylaminoethanereller syreadditionssalte deraf
DK132755C (da) Analogifremgangsmade til fremstilling af benzomorphanderivater eller syreadditionssalte deraf
DK131727C (da) Analogifremgangsmade til fremstilling af oxazinobenzoxaziner eller syreadditionssalte deraf
DK131470B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive thiazolino-pyrimidin-5-on derivater eller syreadditionssalte deraf.